GPX4 and head and neck cancer: GPX4 inhibitor RSL3, as a ferroptosis inducer of head and neck cancer (HNC) cells, can be bind to GPX4 protein and degrade it, thus increasing LPO production and inducing ferroptosis (Dächert et al., 2016).